Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: OH2 Injection in Combination With HX008 for Melanoma. [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating OH2 Injection in combination with HX008 for melanoma, and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Outcomes of Nivolumab in Combination With Relatlimab in Patients With Advanced Melanoma in the Flatiron Database
This clinical trial update reports real-world outcomes for patients with advanced melanoma treated with the nivolumab and relatlimab combina…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Overcoming Primary Resistance to Immunotherapy in Metastatic Melanoma [Phase 2]
A Phase 2 clinical trial investigating ways to overcome primary resistance to immunotherapy in metastatic melanoma has been completed.
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260) [Phase 2]
Phase 2 study CA209-260 in advanced melanoma and bladder cancer examined the relationship between tumor mutation burden and predicted neoant…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: French Clinical Datbase of Melanoma Patients (RIC-Mel)
A French registry study (RIC-Mel) led by Nantes University Hospital to collect data on melanoma of the skin; recruitment is ongoing.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas [Phase 1, Phase 2]
A Phase I/II clinical trial evaluating DYP688 in patients with metastatic uveal melanoma and other GNAQ/11-mutant melanomas; the study is cu…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Melanoma (Morpheus-Melanoma) [Phase 1, Phase 2]
The trial completed Phase 1/2 evaluating multiple treatment combinations in melanoma. Results have been posted.
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: An International Study on Pediatric Patients With Rare Tumors.
An international pediatric clinical trial study focused on rare tumors is currently recruiting, covering multiple tumor types.
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: In Vivo Real-time Detection of Circulating Melanoma Cells
The University of Arkansas is conducting a study to enable in vivo real-time detection of circulating melanoma cells in patients with melano…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma [Phase 2]
A Phase 2 trial evaluating the combination of nivolumab and axitinib in anti-PD-1 refractory advanced melanoma has completed enrollment and …
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: A Study to Test the Benefit of Vitamin B5 in Patients With Melanoma [Phase 1]
A Phase 1 trial is evaluating the safety and potential benefit of Vitamin B5 (pantothenic acid) in patients with melanoma. The study is curr…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the combination of focused ultrasound ablation with PD-1 antibody blockade in advanced solid tumors has been termin…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Observational Study of Nivolumab Monotherapy or in Combination With Ipilimumab in Participants With Advanced Melanoma and in Participants With Adjuvant Nivolumab Therapy
This clinical trial update reports results from an observational study of nivolumab as monotherapy or in combination with ipilimumab in part…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma [Phase 1]
This is a Phase 1 clinical trial evaluating MEDI0562 before surgical resection in head and neck squamous cell carcinoma or melanoma; the stu…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma [Phase 1, Phase 2]
Clinical trial update reporting completion of a phase 1/2 study of the HDAC inhibitor vorinostat in resistant BRAF V600-mutated advanced mel…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma [EARLY_Phase 1]
An early-phase trial evaluated radiation therapy, plasma exchange, and immunotherapy with pembrolizumab or nivolumab for melanoma. The trial…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: A Beta-only IL-2 ImmunoTherapY Study [Phase 1, Phase 2]
Medicennа Therapeutics is evaluating a beta-only IL-2 immunotherapy (MDNA11) in Phase 1/2 across multiple advanced solid tumors; recruitment…
-
CLINICAL_TRIALS withdrawal · 2025-07-09Clinical Trial Update: Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma [Phase 2]
Phase 2 trial of intravenous iron in combination with standard-of-care immunotherapy for melanoma has been withdrawn.
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma [Phase 3]
Clinical trial update on a Phase 3 neoadjuvant study of BCD-217 (Nurulimab + Prolgolimab) in patients with resectable Stage III skin melanom…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin [Phase 1]
A Phase 1 clinical trial assessing the pharmacokinetics and safety of BCD-263 and nivolumab (Opdivo) as monotherapy in patients with advance…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating nivolumab with hydroxychloroquine or nivolumab with ipilimumab plus hydroxychloroquine in advanced melan…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin [Phase 3]
Phase 3 clinical trial evaluating BCD-263 and Opdivo as monotherapy for advanced melanoma of the skin; the study status is ACTIVE_NOT_RECRUI…
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy [Phase 1]
Phase 1 clinical study of CMP-001 in combination with pembrolizumab or as monotherapy for melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors [Phase 1]
This Phase 1 trial assesses Autogene Cevumeran (RO7198457) as a single agent and in combination with atezolizumab across multiple locally ad…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors [Phase 1]
Phase 1 trial of autologous tumor infiltrating lymphocytes with high-dose interleukin-2 in select solid tumors was terminated, with results …